Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FU9QG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,661
Award facts
- Contract value 100% obligated
- $6,661.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,661.37 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). This firm fixed price, competitively awarded contract—with no set-aside designation—was executed on July 22, 2025, with an ultimate completion date of July 23, 2025. The award reflects a rapid fulfillment timeline typical of delivery orders placed against existing contract vehicles. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Multaq (dronedarone) is an antiarrhythmic agent used in cardiac care, consistent with AmerisourceBergen's extensive portfolio of specialty medications and brand-name pharmaceuticals delivered through the DLA supply chain. The contract demonstrates the vendor's capability to meet federal requirements through open competition and fulfill specialized medical supply needs across therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FU9QG?
SPE2DB25FU9QG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FU9QG worth?
The government has obligated $6,661 on SPE2DB25FU9QG.
Is contract SPE2DB25FU9QG an order under another contract?
Yes. SPE2DB25FU9QG is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9QG competed?
The extent of competition for SPE2DB25FU9QG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award